DexLab Overview
- Status
- Private
- Latest Deal Type
- Seed
- (Cancelled)
- Latest Deal Amount
- $167K
- Investors
- 1
DexLab General Information
Description
Developer of a technology that allows to produce dextran from natural waste. The company's technology achieves this process by using molasses and milk whey, enabling doctors to decrease the volume of circulating blood plasma.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Primary Office
- Riga
- Latvia
DexLab Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Seed Round | 06-Nov-2015 | $167K | Cancelled | Startup | ||
| 1. Accelerator/Incubator | 14-Oct-2015 | 000.00 | 000.00 | Completed | Startup |
DexLab Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Commercialization Reactor | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |